Supplementary statement on conjugate meningococcal vaccines.
D002170:Canada; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D018074:Vaccines, Conjugate / Q000008:administration & dosage / Q000494:pharmacology
D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate